DLBCL: The Role of Biosimilar Rituximab

Speaker: Dr. Khalil Al Farsi
Affiliations: Senior Consultant in the Hematology/BMT Department, Sultan Qaboos University Hospital, Muscat, Oman
This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.